Australia markets open in 8 hours 23 minutes

Acrux Limited (ACR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0640+0.0040 (+6.67%)
At close: 04:10PM AEST

Acrux Limited

103-113, Stanley Street
West Melbourne, VIC 3003
Australia
61 3 8379 0100
https://www.acrux.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

NameTitlePayExercisedYear born
Mr. Michael John Kotsanis B.Sc., BSc, GradDipBus, MBusCEO, MD & Executive Director517.86kN/A1966
Ms. Joanna Johnson B.E., BEc, ICAACFO & Company Secretary273.93kN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Corporate governance

Acrux Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.